Emicizumab Prophylaxis in Patients with Hemophilia. with and without Inhibitors

被引：1
|
作者：
Ebbert, Patrick T. [1 ,2 ]
Xavier, Frederico [2 ,3 ]
Seaman, Craig D. [1 ,2 ]
Ragni, Margaret V. [4 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[2] Hemophilia Ctr Western PA, Pittsburgh, PA USA
[3] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA
[4] Univ Pittsburgh, Dept Med, Div Hematol Oncol, Pittsburgh, PA USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-123198
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2416
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors
    Mahlangu, J.
    Oldenburg, J.
    Paz-Priel, I.
    Negrier, C.
    Niggli, M.
    Mancuso, M. E.
    Schmitt, C.
    Jimenez-Yuste, V.
    Kempton, C.
    Dhalluin, C.
    Callaghan, M. U.
    Bujan, W.
    Shima, M.
    Adamkewicz, J. I.
    Asikanius, E.
    Levy, G. G.
    Kruse-Jarres, R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (09): : 811 - 822
  • [2] Severe Bleeding Events in Hemophilia. Patients Receiving Emicizumab Prophylaxis
    Zimowski, Karen L.
    Batsuli, Glaivy M.
    Bryant, Paulette
    McDaniel, Jenny
    Tickle, Kelly
    Meeks, Shannon L.
    Sidonio, Robert F., Jr.
    [J]. BLOOD, 2019, 134
  • [3] COST-EFFECTIVENESS OF EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH HEMOPHILIA A WITHOUT INHIBITORS
    Olasupo, O.
    Matino, D.
    Iorio, A.
    Blackhouse, G.
    Xie, F.
    Tarride, J. E.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S428 - S428
  • [4] ECONOMIC IMPACT OF EMICIZUMAB PROPHYLAXIS FOR HEMOPHILIA A WITH AND WITHOUT INHIBITORS
    Cortesi, P. A.
    Castaman, G.
    Mantovani, L. G.
    [J]. VALUE IN HEALTH, 2020, 23 : S699 - S699
  • [5] Emicizumab Prophylaxis in Hemophilia A with Inhibitors
    Aledort, Louis M.
    Ewenstein, Bruce M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (22): : 2193 - 2193
  • [6] Emicizumab Prophylaxis in Hemophilia A with Inhibitors
    Oldenburg, Johannes
    Mahlangu, Johnny N.
    Kim, Benjamin
    Schmitt, Christophe
    Callaghan, Michael U.
    Young, Guy
    Santagostino, Elena
    Kruse-Jarres, Rebecca
    Negrier, Claude
    Kessler, Craig
    Valente, Nancy
    Asikanius, Elina
    Levy, Gallia G.
    Windyga, Jerzy
    Shima, Midori
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (09): : 809 - 818
  • [7] Emicizumab for hemophilia A without inhibitors
    Cafuir, Lorraine
    Kruse-Jarres, Rebecca
    Mancuso, Maria Elisa
    Kempton, Christine L.
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (07) : 515 - 524
  • [8] COST-CONSEQUENCE ANALYSIS OF EMICIZUMAB PROPHYLAXIS FOR SEVERE HEMOPHILIA A PATIENTS WITHOUT INHIBITORS
    Cortesi, P. A.
    Castaman, G.
    Mantovani, L. G.
    [J]. VALUE IN HEALTH, 2020, 23 : S696 - S696
  • [9] Emicizumab Prophylaxis in Hemophilia A with Inhibitors REPLY
    Oldenburg, Johannes
    Levy, Gallia G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (22): : 2194 - 2195
  • [10] Reliable Routine Prophylaxis, Relief for Patients Clinical Experience with Emicizumab in Hemophilia A without Inhibitors
    Neubacher, Daniel
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2019, 46 (04) : 294 - 297
12345